SPCX stock falls below its IPO price amid lock-up expiry concerns and operational setbacks, wiping out over $1.2 trillion in market capitalization. SpaceX shares have dropped to around $108, a 52% decline from their post-IPO peak of $225.64, erasing over $1.2 trillion in m
NuScale Power's market cap is $3 billion NuScale Power Corp is scheduled to report second-quarter earnings after market close on Aug. 5. The company's stock price has plunged nearly 50% this year. Analysts believe nuclear energy will be a $10 trillion opportunity
Original Medicare lacks an out-of-pocket maximum, leaving beneficiaries liable for 20% of Part B costs without a cap. Original Medicare imposes no annual out-of-pocket limit, requiring beneficiaries to pay 20% of Part B costs after a $283 deductible. For a cancer patient w
The Vanguard S&P 500 ETF surpasses $1.7 trillion in assets, underscoring the appeal of passive, long-term market strategies. The Vanguard S&P 500 ETF (VOO) has grown to $1.7 trillion in assets, making it the world’s largest exchange-traded fund. The fund tracks the S&P 500
Three directors disposed of shares to cover tax liabilities tied to vesting, holding no elective reduction in company exposure. Three GlobalFoundries Inc. (NASDAQ:GFS) directors, including Camilla Languille, sold 1,671 shares on July 29, 2026, to cover tax obligations from
Novo Nordisk’s experimental heart drug Ziltivekimab missed key trial goals, eroding investor confidence in its growth beyond weight-loss treatments. Novo Nordisk (NVO) shares plunged as much as 8.6% after its experimental heart drug Ziltivekimab failed the primary endpoint
A GlobalFoundries director sold 1,671 shares to cover tax withholding, holding 9,202 shares post-transaction amid a $27.4 billion market cap. A GlobalFoundries Inc. (NASDAQ:GFS) director sold 1,671 shares on July 29, 2026, at a weighted average price of $49.02, totaling ap
The sale reduces the director’s stake to 14,867 shares amid a 41% stock gain over the past year. A GlobalFoundries Inc. (NASDAQ:GFS) director sold 4,000 shares on July 20, 2026, at a weighted average price of $58.22, according to an SEC filing. The transaction occurred as
An IQVIA insider sold 558 shares at $245.21 before the stock closed at $237.82 the following day. An IQVIA Holdings Inc. (NYSE:IQV) executive sold 558 shares on July 29, 2026, for $136,827, according to an SEC filing. The transaction occurred at $245.21 per share, above th
Revolution Medicines' stock jumps after positive phase III trial results and high-profile investor purchases, including Stanley Druckenmiller's $7 billion fund. Shares of Revolution Medicines (RVMD) have climbed 134% year-to-date, driven by strong clinical trial results an
ادخل بحساب جوجل لمشاركة رأيك والتفاعل مع الأخبار — بلا كلمة مرور.
إيميلك يبقى موثّقاً وخصوصيتك محفوظة.